Oxcarbazepine Tablet, Film Coated
Product Images NDC 0615-8634

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 0615-8634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Oxcarbazepine Tabs 8634 8635 8636 1)

FDA Label Image

Logo (Oxcarbazepine Tabs 8634 8635 8636 10)

FDA Label Image

Principal Display Panel (Oxcarbazepine Tabs 8634 8635 8636 11)

This is information about Oxcarbazepine Tablets USP 150 mg. The tablets are produced by ANI Pharmaceuticals and packaged by Vanguard in Glasgow. The medication is meant for institutional use only and should be stored at a temperature between 20°C to 25°C. Each tablet contains 150 mg of Oxcarbazepine and should be used as directed in the package insert. The lot number for the tablets is 8634, with NDC 62559-220-01.*

FDA Label Image

Principal Display Panel (Oxcarbazepine Tabs 8634 8635 8636 12)

This is a pharmaceutical packaging label for Oxcarbazepine tablets USP 300 mg. The tablets are manufactured by Esjay for ANI Pharmaceuticals. The package is labeled with the NDC code 62559-221-01 and is distributed by VANGARD in Glasgow, KY. The typical dosage and storage instructions are provided on the label as well. The text includes lot numbers and manufacturing details for tracking purposes.*

FDA Label Image

Principal Display Panel (Oxcarbazepine Tabs 8634 8635 8636 13)

This is information about the medication Oxcarbazepine in tablet form, specifically detailing the Oxcarbazepine Tablet USP 600 mg. The tablets are manufactured by Esjay for ANI Pharmaceuticals and packaged by Vangard in Glasgow, KY. The text includes details like lot numbers, expiration dates, and instructions for storage and usage. The tablets are for institutional use only and contain Oxcarbazepine USP 600 mg. Multiple lot numbers and manufacturing details are provided throughout the text. It is essential to consult the package insert for full prescribing information and follow the storage temperature guidelines.*

FDA Label Image

Fig-1 (Oxcarbazepine Tabs 8634 8635 8636 2)

FDA Label Image

Fig-2 (Oxcarbazepine Tabs 8634 8635 8636 3)

FDA Label Image

Fig-3 (Oxcarbazepine Tabs 8634 8635 8636 4)

FDA Label Image

Fig-4 (Oxcarbazepine Tabs 8634 8635 8636 5)

FDA Label Image

Table-1 (Oxcarbazepine Tabs 8634 8635 8636 6)

This text lists common symptoms that may occur in individuals with certain health conditions, including nausea, confusion, tiredness (lack of energy), more frequent or severe seizures, and headaches. These symptoms may indicate various medical issues and should be evaluated by a healthcare professional.*

FDA Label Image

Table-2 (Oxcarbazepine Tabs 8634 8635 8636 7)

This text appears to be describing various signs and symptoms that could indicate a serious medical condition. It mentions symptoms such as swelling of the face, eyes, lips, or tongue, trouble swallowing or breathing, skin rash, hives, fever, swollen glands, sore throat, painful sores, yellowing of the skin or eyes, unusual bruising or bleeding, fatigue, weakness, muscle pain, and frequent infections. These symptoms may warrant immediate medical attention and evaluation by a healthcare professional.*

FDA Label Image

Table-3 (Oxcarbazepine Tabs 8634 8635 8636 8)

This text seems to be describing different warning signs and symptoms related to mental health, specifically focusing on thoughts of suicide, depression, anxiety, and other negative emotions. It also mentions behaviors such as aggression, restlessness, and changes in activity levels that may indicate a worsening mental state. These indicators highlight the importance of seeking help and support for individuals experiencing such difficulties.*

FDA Label Image

Med-guide (Oxcarbazepine Tabs 8634 8635 8636 9)

This text lists common symptoms associated with a possible medical condition or side effects of medication. Some symptoms mentioned include dizziness, sleepiness, double vision, nausea, vomiting, problems with vision, trembling, problems with walking and coordination (unsteadiness), rash, and headache. These symptoms may require medical attention or evaluation by a healthcare professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.